
Franklin Laboratories India Profile
Key Indicators
- Authorised Capital ₹ 1.05 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 58 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.53 Cr
- Satisfied Charges ₹ 9.06 Cr
- Revenue Growth -4.52%
- Profit Growth 61.29%
- Ebitda 26.65%
- Net Worth 3.97%
- Total Assets -0.69%
About Franklin Laboratories India
Franklin Laboratories India Pvt Ltd (FLIPL) was founded in India on 27 October 1966 and has a glorious history of 58 years and four months. Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.05 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹7.53 Cr. The company has closed loans amounting to ₹9.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Akshay Sareen, Anju Thapar, Krishan Sareen, and One other member serve as directors at the Company.
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231PB1966PTC002676
- Company No.
002676
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 1966
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Franklin Laboratories India Pvt Ltd offer?
Franklin Laboratories India Pvt Ltd offers a wide range of products and services, including Health Conditions, Liver Care, Vitamins & Supplements, Multivitamins.
Who are the key members and board of directors at Franklin Laboratories India?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Akshay Sareen ![]() | Director | 05-Jun-2018 | Current |
Anju Thapar ![]() | Director | 05-Jun-2018 | Current |
Krishan Sareen ![]() | Director | 27-Oct-1966 | Current |
Ajay Sareen ![]() | Director | 27-Oct-1966 | Current |
Financial Performance of Franklin Laboratories India.
Franklin Laboratories India Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.52% decrease. The company also saw a substantial improvement in profitability, with a 61.29% increase in profit. The company's net worth moved up by a moderate rise of 3.97%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Franklin Laboratories India?
In 2023, Franklin Laboratories India had a public holding of 22.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Franklin Pharmaceuticals India Private Limited
Akshay Sareen, Anju Thapar and 2 more are mutual person
Charges (Loans)
₹7.53 Cr
₹9.06 Cr
Charges Breakdown by Lending Institutions
- Others : 7.50 Cr
- Ashok Layland Finance Ltd. : 0.03 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
25 Oct 2023 | Others | ₹1.50 M | Open |
29 Aug 2015 | Others | ₹7.35 Cr | Open |
28 Feb 1998 | Ashok Layland Finance Ltd. | ₹0.32 M | Open |
11 Sep 1998 | State Bank Of India | ₹1.65 M | Satisfied |
07 Mar 1996 | State Bank Of India | ₹0.40 M | Satisfied |
How Many Employees Work at Franklin Laboratories India?
Franklin Laboratories India has a workforce of 91 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Franklin Laboratories India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Franklin Laboratories India's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.